“…In our previous prospective non-randomized trial, which enrolled T1D YA patients from a fairly homogeneous background (age 19.8 ± 1.6 years, 83% White, 86% Non-Hispanic, and 86% privately insured), enrollees who participated in CoYoT1 Clinic had improved clinic attendance compared to control group patients (71% of CoYoT1 patients attended four clinic visits over the study year, meeting ADA recommendations, versus 0% of control group patients), and trended towards completing HbA1c tests more frequently than control patients [24,25]. Patients in the CoYoT1 intervention also reported decreased diabetes distress, increased confidence in their abilities to manage their diabetes, and improved ability to communicate with others about their diabetes, compared to the control group.…”